Invention Grant
- Patent Title: Thromboembolic disease markers
-
Application No.: US14886463Application Date: 2015-10-19
-
Publication No.: US10023914B2Publication Date: 2018-07-17
- Inventor: Eduardo Salas , José Manuel Soria , Miroslava Ogorelkova , Roberto Elosua , Joan S. Vila , Sergio Castillo
- Applicant: Gendiag.exe, S.L.
- Applicant Address: ES Barcelona
- Assignee: Gendiag.exe, S.L.
- Current Assignee: Gendiag.exe, S.L.
- Current Assignee Address: ES Barcelona
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: EP11170235 20110616
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12Q1/68 ; C12Q1/6883 ; C12Q1/6827 ; C12Q1/6837
Abstract:
The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.
Public/Granted literature
- US20160102355A1 THROMBOEMBOLIC DISEASE MARKERS Public/Granted day:2016-04-14
Information query
